Brio Capital Master Fund Ltd. 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-20 11:56 am Unchanged | 2024-11-14 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Brio Capital Master Fund Ltd. | 0 0.900% | 0 (Unchanged) | Filing |
| 2024-07-23 3:09 pm Unchanged | 2024-07-15 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Brio Capital Master Fund Ltd. | 0 9.830% | 0 (Unchanged) | Filing |